신경과학 시장 보고서 : 구성요소별, 기술별, 최종사용자별, 지역별(2026-2034년)

The global neuroscience market size reached USD 37.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 48.6 Billion by 2034, exhibiting a growth rate (CAGR) of 3.07% during 2026-2034. Increasing prevalence of neurological disorders, rising investment in research and development (R&D), technological advancements in neuroimaging tools, growing awareness of mental health issues, expanding applications in neuroinformatics and neuroprosthetics, burgeoning aging populations, and supportive government policies are some of the factors facilitating the market growth.

Neuroscience Market Analysis:

• Major Market Drivers: Based on the neuroscience market analysis, one key driver of market expansion is the increased funding put into research and development (R&D) efforts, by industry players and research institutions aimed to create treatments. Another contributing factor to market growth is the rising occurrence of disorders including epilepsy. In line with this, the escalating prevalence of neurological ailments in aging population has surged the demand for new treatments options, which is further providing a considerable thrust to the market growth. The market is also supported by the investments by the governments of various nations to support research and growing collaborative activities among industries and academia.
• Key Market Trends: The neuroscience market is growing due to the rising prevalence of neurological disorders like Alzheimer's, brain cancer, and epilepsy. For example, Alzheimer's cases are expected to reach 13 Million in the US by 2050. Technological advancements, such as the US BRAIN initiative, are driving research into brain diseases. Digital healthcare innovations are enhancing management and boosting the adoption of neuroscience devices. Furthermore, increased public awareness, as highlighted by initiatives such as "Neuroscience Is" by the American Academy of Neurology, is expanding the market. However, the COVID-19 pandemic temporarily slowed growth due to disruptions in healthcare services.
• Geographical Trends: North America is at the forefront of advancements in neuroscience due to investments in research and development (R&D), an incidence of neurological disorders and a well-established healthcare system. The United States hosts companies and research institutions that fuel innovation and market expansion. In Europe, countries such as Germany, the UK and France play a role in neuroscience research, with government backing and efficient healthcare systems. The Asia Pacific region is witnessing progress driven by increased healthcare spending, a growing population and heightened awareness of neurological conditions.
• Competitive Landscape: The competitive landscape of the market is characterized by the presence of key neuroscience companies, such as Alpha Omega Engineering, Biobserve GmbH, Blackrock Neurotech, Doric Lenses Inc., General Electric Company, Kernel, Laserglow Technologies, Mightex Systems, NeuroNexus Technologies Inc., Noldus Information Technology B.V., Plexon Inc., Prizmatix Ltd. and Siemens AG.
• Challenges and Opportunities: The neuroscience market encounters umpteen obstacles, such as research and development (R&D) expenses, intricate regulatory processes and the demand for highly trained professionals. The intricacies of disorders create barriers to understanding and creating effective therapies. Moreover, the absence of standards and biomarkers for numerous neurological diseases adds complexity to diagnosing and treating these conditions. Nevertheless, these challenges also bring about opportunities for progress and creativity. Technological advancements, like artificial intelligence (AI) and machine learning (ML) provide novel approaches to analyze and interpret data potentially leading to groundbreaking discoveries.

Neuroscience Market Trends:

Increasing Prevalence of Neurological Disorders

The global rise in neurological conditions such as Alzheimer's disease, Parkinson's disease, and epilepsy is a major factor driving the growth of the neuroscience market. In the United States, Alzheimer's currently affects around 7 million people, and this number is projected to nearly double by 2050. This increase is largely due to the aging population, which is more prone to neurodegenerative diseases. As a result, there is a growing demand for advanced diagnostic tools and effective treatment strategies. This has led to intensified research into the biological mechanisms underlying these disorders, with the goal of developing more targeted and effective therapies. The introduction of AI-powered diagnostic systems, such as the Philips CT 3500 launched in 2023, reflects the rapid innovation in the instrument segment, enhancing the precision and speed of neurological assessments. Moreover, the hospital sector is expected to witness the fastest growth, fueled by a rise in neurological admissions and the expansion of healthcare infrastructure, which is increasing the demand for sophisticated diagnostic and therapeutic solutions.

Rising Investment in Neuroscience Research and Development

The neuroscience field is experiencing a surge in funding from both public institutions and private enterprises. These investments support a wide range of initiatives, from fundamental brain research to the development of advanced technologies, such as brain mapping and neural data integration. Government agencies and philanthropic organizations are particularly focused on understanding brain function and dysfunction, while private companies-especially in the biotech and pharmaceutical sectors-are investing in the development of new drugs and therapies. These investments are also strengthening the consumables segment, with companies such as B. Braun SE and GE Healthcare offering durable, user-friendly products like patient monitors and injectors that enhance the efficiency of neurological care. This financial support is accelerating the pace of scientific discovery and helping to translate research findings into practical clinical applications.

Technological Advancements in Neuroimaging Tools

Recent advancements in neuroimaging technologies-including MRI, PET, and EEG-have significantly improved the diagnosis and monitoring of neurological disorders. These tools now offer higher resolution, faster imaging speeds, and more accurate data analysis through advanced algorithms. This has enabled earlier detection of brain abnormalities and more precise localization of lesions, which is critical for effective treatment planning. Additionally, neuro-microscopy is emerging as a transformative area, with companies like Danaher Corporation and Carl Zeiss AG developing ultra-miniature electronic microscopes that can not only detect but may also help reverse neurological damage. These innovations are expanding the capabilities of clinicians and researchers, making neuroimaging an essential component of modern neuroscience.

Neuroscience Industry Segmentation:

Breakup by Component:

• Instruments and Consumables
• Software and Services

Instruments and consumables accounts for the majority of the market share

The instruments and consumables segment is driven by the increasing demand for advanced diagnostic and surgical tools in medical and research settings. Technological advancements such as precision instruments and high-throughput consumables are enhancing efficiency and accuracy in diagnostics and experimental procedures, thereby boosting market growth. Moreover, expanding applications in genomic and proteomic research are driving the need for specialized instruments and consumables tailored for molecular analysis and sample preparation. Furthermore, the segment benefits from rising healthcare expenditure globally, which supports investments in state-of-the-art equipment and disposable consumables that ensure patient safety and procedural efficacy. Additionally, regulatory developments mandating the use of certified instruments and sterile consumables in healthcare facilities are influencing market dynamics, encouraging manufacturers to innovate and comply with stringent quality standards.

Breakup by Technology:

• Brain Imaging
• Neuro-Microscopy
• Electrophysiology
• Neuroproteomic Analysis
• Animal Behaviour Analysis
• Others

Brain imaging accounts for the majority of the market share

The brain imaging segment is driven by the increasing demand for advanced diagnostic capabilities in neurological disorders. With conditions such as Alzheimer's disease, Parkinson's disease, and strokes on the rise globally, there is a growing need for accurate and early detection methods to facilitate prompt treatment and management. Technological advancements in imaging modalities like magnetic resonance imaging (MRI), positron emission tomography (PET), and computed tomography (CT) have significantly enhanced resolution, speed, and sensitivity, allowing for detailed visualization of brain structures and functions. These advancements not only enable clinicians to pinpoint abnormalities and track disease progression more effectively but also support the development of personalized treatment plans tailored to individual patient needs. Apart from this, the integration of artificial intelligence (AI) and machine learning (ML) algorithms into brain imaging technologies has further bolstered diagnostic accuracy and efficiency, driving adoption across clinical and research settings.

Breakup by End User:

• Hospitals
• Diagnostic Laboratories
• Research and Academic Institutes
• Others

The hospitals segment is driven by the increasing demand for specialized healthcare services, advanced medical technologies, and comprehensive patient care. Hospitals are expanding their facilities and services to cater to growing populations and rising healthcare needs, including surgical procedures, emergency care, and chronic disease management. Additionally, advancements in medical treatments and therapies, coupled with the integration of digital health technologies, are enhancing hospital efficiency and patient outcomes. Collaborations with pharmaceutical companies and research institutions further drive innovation in medical treatments and diagnostic capabilities within hospital settings.

The diagnostic laboratories segment is driven by the increasing prevalence of diseases requiring early and accurate diagnosis, such as cancer, cardiovascular disorders, and infectious diseases. Diagnostic labs play a crucial role in disease detection, monitoring, and treatment planning, leveraging advanced diagnostic technologies like molecular diagnostics, next-generation sequencing, and advanced imaging techniques. Moreover, the shift towards personalized medicine and precision diagnostics is driving demand for specialized tests and biomarker analysis, contributing to the growth of diagnostic laboratories worldwide. Collaborations with healthcare providers and research institutes enhance the development and adoption of innovative diagnostic solutions.

The research and academic institutes segment is driven by the expanding scope of scientific research across various disciplines, including medicine, biotechnology, and neuroscience. These institutes contribute significantly to advancements in healthcare through fundamental research, clinical trials, and translational research aimed at developing new therapies, drugs, and medical devices. Funding from government grants, private foundations, and collaborations with pharmaceutical companies supports research initiatives and infrastructure development in academic institutions. Additionally, partnerships with hospitals and diagnostic laboratories facilitate knowledge exchange and the application of research findings in clinical practice, driving innovation and improving patient care globally.

Other healthcare segments, such as clinics and ambulatory surgical centers, are driven by the increasing demand for outpatient services, convenience, and cost-effective healthcare delivery models. These facilities offer specialized medical services, preventive care, and minor surgical procedures outside traditional hospital settings. The rise of chronic diseases, aging populations, and healthcare reforms emphasizing preventive care and outpatient treatments are fueling the growth of clinics and ambulatory centers.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America leads the market, accounting for the largest neuroscience market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The North America regional market is driven by the increasing prevalence of chronic diseases such as cardiovascular diseases, diabetes, and obesity, which have heightened demand for advanced healthcare solutions and medical devices. This dominance is largely due to the significant presence of companies focused on developing, manufacturing, and commercializing devices for diagnosing and treating neurological conditions. For example, in February 2022, CERENOVUS introduced the EMBOGUARD, an advanced balloon guide catheter designed for use in endovascular procedures, particularly for patients with acute ischemic stroke. The Asia Pacific region is projected to experience the fastest growth in the coming years. This growth is fueled by increasing investments in healthcare infrastructure and high levels of healthcare spending, which are driving the expansion of the neuroscience industry. A notable example is China's "China Brain Project" (CBP), launched in September 2022 with an initial investment of USD 746 Million. The project aims to explore the neural basis of cognitive functions, brain-inspired computing, and advancements in diagnosing and treating brain disorders. Such government initiatives are expected to accelerate research and development in neuroscience, further boosting market growth.

Competitive Landscape:

• The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the neuroscience include Alpha Omega Engineering, Biobserve GmbH, Blackrock Neurotech, Doric Lenses Inc., General Electric Company, Kernel, Laserglow Technologies, Mightex Systems, NeuroNexus Technologies Inc., Noldus Information Technology B.V., Plexon Inc., Prizmatix Ltd., Siemens AG., etc.
• Key players in the neuroscience market are actively engaged in enhancing product innovation and technological advancements to maintain competitiveness and meet evolving consumer demands. They focus on developing more efficient diesel engines with improved fuel efficiency and reduced emissions to comply with stringent environmental regulations globally. These efforts also include integrating advanced monitoring and control systems into their generators to enhance reliability and performance. Additionally, market leaders are expanding their product portfolios to offer a wider range of power capacities and application-specific solutions, catering to diverse industrial and commercial sectors. Strategic partnerships and collaborations with technology providers are also prevalent among key players to leverage expertise in hybrid power solutions that integrate renewable energy sources. Moreover, there is a notable emphasis on expanding their geographical presence through acquisitions and joint ventures, particularly in emerging markets like Asia Pacific and Latin America, where demand for reliable power solutions is growing rapidly.

Key Questions Answered in This Report

• 1.What was the size of the global neuroscience market in 2025?
• 2.What is the expected growth rate of the global neuroscience market during 2026-2034?
• 3.What are the key factors driving the global neuroscience market?
• 4.What has been the impact of COVID-19 on the global neuroscience market?
• 5.What is the breakup of the global neuroscience market based on the component?
• 6.What is the breakup of the global neuroscience market based on the technology?
• 7.What are the key regions in the global neuroscience market?
• 8.Who are the key players/companies in the global neuroscience market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Neuroscience Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Component

• 6.1 Instruments and Consumables
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Software and Services
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Technology

• 7.1 Brain Imaging
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Neuro-Microscopy
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Electrophysiology
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Neuroproteomic Analysis
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Animal Behaviour Analysis
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Others
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Diagnostic Laboratories
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Research and Academic Institutes
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Alpha Omega Engineering
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Biobserve GmbH
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Blackrock Neurotech
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Doric Lenses Inc.
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 General Electric Company
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Kernel
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Laserglow Technologies
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Mightex Systems
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 NeuroNexus Technologies Inc.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Noldus Information Technology B.V.
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 Plexon Inc.
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
  • 14.3.12 Prizmatix Ltd.
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
  • 14.3.13 Siemens AG
    • 14.3.13.1 Company Overview
    • 14.3.13.2 Product Portfolio
    • 14.3.13.3 Financials
    • 14.3.13.4 SWOT Analysis